[09/30/2012] 丁元华博士一席谈
时间: Sunday, September 30, 2012 , 2:00 p.m.-3:30 p.m.
地点: MIT Sloan E51-372. Address: 2 Amherst Street, Cambridge, MA
主办：波士顿清华校友会，未名紫荆创业联盟
协办：MIT CSSA
嘉宾介绍：
Dr. Yuan-Hua Ding is a Senior Director and Head of Pfizer External R&D Innovation (ERDI) – Asia/Pacific, Pfizer Worldwide Research & Development (WRD). He is also a member of the ERDI leadership team. In
this capacity, he partners with colleagues in ERDI and Pfizer Business Development Group to evaluate academic & biotech research capabilities in Asia/Pacific region, seek opportunities to incubate early biotech
companies, build and manage a research network of academic institutes, biotech companies and Contracted Research Organizations (CROs). He liaises with therapeutic area and technology research unit leaderships in accessing the sciences, technologies and products needed to support Pfizer mission in Asia. Since June 2011, Dr. Yuan-Hua Ding also acts as Interim Head of ERDI Anti-Infective, leading a cross functional team to search and seek external novel anti-infective programs by working with biotech and pharmaceutical companies globally.
Prior to his current role, Dr. Ding served a variety of roles in the Pfizer R&D division, including Head of Asia External Science and Technology, Head of Structural Biology at the RTC Research Technology Center (RTC) in Cambridge, MA, Associate Research Fellow and Senior Research Scientist. As the Head of the RTC Structural Biology, he oversaw a group of scientists responsible for protein production, characterization, crystallization, crystallography and structure-based drug design. His group supported structural based drug design portfolio of 10+ programs, through collaborative effort between RTC, Pfizer global structural biology groups and therapeutic area project teams, covering oncology, diabetes, inflammation and CNS. He also served as project leaders for several drug discovery programs.
Dr. Ding received a bachelor’s degree in Electronic Engineering from Peking University in 1987 and a master’s degree in Biophysics from Tsinghua University in 1990. In 1996, after completed his doctoral studies in Biochemistry with Prof. John Rosenberg and Roger Hendrix at the University of Pittsburgh, he moved to Harvard University to be a postdoctoral fellow with Prof. Don Wiley. Dr. Ding’s postdoctoral work
focused on structural and biophysical aspects of molecular interactions among T-cell receptor (TCR), major histocompatibility complex (TCR) and peptide antigens. While in Dr. Wiley’s Lab, Dr Ding also collaborated with Dr. Judah Folkman of Boston Children’s Hospital on structural studies of endostatin, a protein shown to be a potent angiogenesis inhibitor in mouse model.
Dr. Yuan-Hua Ding is the founder and secretary of the New England Structural Biology Association, a non-profit organization dedicated to bringing together industrial scientists with a shared version of using protein structures to enable the design of novel therapeutics. Dr. Ding also serves on the Editorial Board for the Chemical Biology and Drug Design journal.
波士顿清华校友会成立于1976年。自成立以来，校友会一直致力于服务在波士顿地区学习、工作和生活的清华校友（包括北京清华大学和新竹国立清华大学）。林家翘、李诗颖等著名华人科学家都先后担任过校友会会长。2011年，波士顿清华校友会得到美国联邦政府批准，被认定为符合501(c)(3)免税条款的公共慈善机构(Public Charity)。波士顿地区现有约2000名清华校友，分布在学术，教育，生物，制药，电子，信息，金融服务，建筑设计，法律服务等多个行业。波士顿清华校友会的宗旨是
联谊与互助；职业成长与发展；回馈母校与社会。波士顿清华校友会网站：http://www.tsinghua-boston.org/
未名紫荆创业联盟由波士顿清华大学校友会，北京大学新英格兰校友会联合打造，致力于嫁接美国东部地区创业人才与国内园区的创业资源，为有创业想法的年轻校友搭建相互交流、启发、合作创业的平台。联盟定位于强调”实践”创业想法，活动将主要以”风暴讨论”形式为主，每一期设立一个主题，主题或源于俱乐部成员的创业项目、或源于俱乐部成员集中关心的热点问题，并辅以校友企业参观，讲座，组团回国考察等活动。竭诚邀请您通过以下链接加入我们联盟
http://groups.google.com/group/alumni-venturepractice-club?hl=en.
未名紫荆创业联盟网站：www.weimingzijing.com
